enVVeno Medical (NVNO) Debt Ratio (2017)

enVVeno Medical's (NVNO) quarterly Debt Ratio came in at 0.12 in Q4 2017.

enVVeno Medical (NVNO) Debt Ratio (2017) Analysis & Trends

enVVeno Medical's Debt Ratio history runs 1 years deep, the most recent figure standing at 0.12 for Q4 2017.

On a quarterly basis, Debt Ratio changed N/A year-over-year to 0.12 in Q4 2017; TTM through Dec 2017 was 0.12, a N/A change from a year earlier, with the FY2017 full-year figure at 0.12, changed N/A from the prior year.
Debt Ratio steadied at 0.12 in Q4 2017 per NVNO's latest filing.
Across five years, Debt Ratio topped out at 0.12 in Q4 2017 and bottomed at 0.12 in Q4 2017.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn	0.31
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn	0.32
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn	0.30
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn	0.25
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn	0.04
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn	-
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn	0.30
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn	0.27
9	Smith & Nephew	25.80 Bn	25.22 Bn	-	0.30
10	enVVeno Medical	2.75 Mn	2.75 Mn	-	-

Historic Data

Download Data

Date	Value
Dec 31, 2017	0.12